PTCH1 and melanoma: In order to confirm HH-GLI pathway activation in melanoma cell lines, we analyzed relative gene and protein expression levels of the pathway components (GLI1, GLI2, GLI3, and PTCH1) on a panel of 14 human melanoma cell lines with different genetic backgrounds.